Pea peptides
SupplementFood-derived bioactive peptides
Very thin human evidence
- Regulatory standing. Sold as a supplement, not an approved drug
- Animal / preclinical only. Evidence is largely animal or in-vitro
- No registered human trials. Nothing registered on ClinicalTrials.gov
- No sources. Nothing cited to verify
Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.
What it is
Pea peptides are short protein fragments produced by breaking down pea protein, usually through enzymatic hydrolysis, and are sold as dietary supplements or food ingredients. Laboratory work suggests some fragments may have antioxidant, blood pressure related (ACE-inhibitory), or other bioactive properties, though how much survives digestion to act in the body is unclear.
What the evidence shows
There are no registered human clinical trials, and the roughly two dozen published papers are mostly laboratory and animal studies, so any health effects in people remain unestablished. Pea peptides are not FDA-approved for any condition.
Registered human trials
Live from ClinicalTrials.gov, refreshed daily.
Published literature
Live from Europe PMC. This is how much has been published, not how much is proven in humans.
Enzymatic Pea Protein Hydrolysates Are Active Trypsin and Chymotrypsin Inhibitors.
Positive Effect of a Pea-Clam Two-Peptide Composite on Hypertension and Organ Protection in Spontaneously Hypertensive Rats.
Reducing the allergenicity of pea protein based on the enzyme action of alcalase.
Anti-fatigue effects of pea (<i>Pisum sativum</i> L.) peptides prepared by compound protease.
Sources
Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.